Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03537768 · ClinicalTrials.gov registry record · Phase 4
Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg
A Phase 4 study, sponsored by Kimberly Myer.
- Terminated
- Registry status
- Phase 4
- Development phase
- 532
- Enrollment target
NCT03537768: Clinical Trial Phase 4 study, sponsored by Kimberly Myer.
NCT03537768 is a Phase 4 study that was terminated before completion, run by Kimberly Myer. The registered enrollment target is 532 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03537768, a Phase 4 study, was terminated before completion, sponsored by Kimberly Myer.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 532 participants
- Enrollment target
Study Summary
The proposed research study is a Phase IIb, multi-center, single-blind, randomized study of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg to evaluate EC effectiveness in women with weight ≥ 80 kg who present within 72 hours of unprotected intercourse.
Interventions
- DRUG Ulipristal Acetate
- DRUG Levonorgestrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2022-04-20 |
| Phase | Phase 4 |
Why NCT03537768 stopped before completion
NCT03537768 is an interventional study that assigns participants to a tested intervention. The registered 532 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Ulipristal Acetate is the first listed.
NCT03537768 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03537768 about?
NCT03537768 is a clinical study titled "Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg". The proposed research study is a Phase IIb, multi-center, single-blind, randomized study of UPA 30 mg, LNG 1.5 mg and LNG 3.0 mg to evaluate EC effectiveness in women with weight ≥ 80 kg who present within 72 hours of unprotected intercourse.
What is the current status of trial NCT03537768?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 532 participants. The study started on 2018-07-12. Estimated completion is 2022-04-20.
What interventions are being tested in trial NCT03537768?
The interventions under investigation include: Ulipristal Acetate (DRUG), Levonorgestrel (DRUG).
Who is sponsoring clinical trial NCT03537768?
This trial is sponsored by Kimberly Myer, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03537768's enrollment target sits among peer trials
532 157th of 2000 higher than 1,844 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05793151 · 532 participants · NA
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- NCT06378866 · 532 participants · Phase 2
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- NCT07219173 · 531 participants · Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- NCT04910685 · 534 participants · Phase 2
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI